Nitroimidazole derivatives: Non-randomness sister chromatid exchanges in human peripheral blood lymphocytes

Journal of Applied Toxicology

Volumn 29, Issue 3, 2009, Pages 248-254

  Carballo, Marta Ana ^a   Martinez, Romari Alejandra ^b   Mudry, Marta Dolores ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

Biomarkers; Chromosomal damage; Genomic instability; Genotoxicity; Nitroimidazoles

Indexed keywords

BIOLOGICAL MARKER; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; ORNIDAZOLE;

ADULT; ARTICLE; BLOOD CULTURE; CELL PROLIFERATION; CHROMOSOME; CHROMOSOME BAND; CHROMOSOME DAMAGE; CHROMOSOME SIZE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; FEMALE; GENOME ANALYSIS; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MITOSIS INDEX; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

BIOLOGICAL MARKERS; CELL DIVISION; CELLS, CULTURED; CHROMOSOME BANDING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METRONIDAZOLE; MITOTIC INDEX; MUTAGENICITY TESTS; MUTAGENS; NITROIMIDAZOLES; ORNIDAZOLE; SISTER CHROMATID EXCHANGE; YOUNG ADULT;

EID: 64549104649     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1403     Document Type: Article

References (62)

1. Avani G, Rao MV. 2007. Genotoxic effects in human lymphocytes exposed to arsenic and vitamin A. Toxicol. in Vitro 21: 626-631.
2. Azzalin CM, Mucciolo E, Bertoni L, Giulotto E. 1997. Fluorescence in situ hybridization with a synthetic (T2AG3)n polynucleotide detects several intrachromosomal telomere-like repeats on human chromosomes. Cytogenet. Cell Genet. 78(2): 112-115.
3. Bakopoulou A, Mourelatos D, Tsiftsoglou AS, Mioglou E, Garefis P. 2008. Sister chromatid exchange, chromosomal aberrations and deleys in cell-cycle kinetics in human lymphocytes induced by dental composite resin eluates. Mutat. Res. 649: 79-90.
4. Barrios L, Miro R, Caballin M, Fuster C, Guedea F, Subias A, Egozcue J. 1989. Cytogenetic effects of radiotherapy: Breakpoint distribution in induced chromosome aberrations. Cancer Genet. Cytogenet. 41(1): 6170.
5. Becker N, Thorland E, Denison S, Phillips L, Smith D. 2002. Evidence that instability within the FRA3B region extends four megabases. Oncogene 57: 8713-8722.
6. Carballo MA, Alvarez S, Boveris A. 1993. Cellular stress by light and rose bengal in human lymphocytes. Mutat. Res. 288: 215-222.
7. Carballo MA, Palermo A, López Nigro M, Andrioli N, Vázquez R, Mudry M. 2001. Mutagenicidad quimica y evaluación de daño potencial mediante Ensayos de Corto Plazo (ECT). A. Toxicol. Arg. 9(1): 4-8.
8. Carballo MA, Palermo A, Mudry M. 2004. Toxicogenetic evaluation of metronidazole treatment of women infected with Trichomona vaginalis. Ann. Trop. Med. Parasitol. 98(2): 139-147.
9. Corbin S, Neilly M, Espinosa 3rd R, Davis E, McKeithan T, Le Beau M. 2002. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res. 62(12): 3477-3484.
10. Cortada CM, López Nigro M, Carballo MA. 2006. Cytotoxicity and P glycoprotein in treatment with niotroimidazoles. Theoria 15(2): 34-40.
11. + ATPase systems in cultured mammalian cells. Mutat. Res. 102: 1-12.
12. De Meo M, Vanelle P, Bernardi E, Laget M, Maldonado J, Jentzer O, Crozet MP, Dumenil G. 1992. Evaluation on mutagenic and genotoxic activities of 48 nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest. Environmental and Molecular Mutagenesis 19: 167-170.
13. Dobías L, Cerna M, Rossner P, Sram R. 1994. Genotoxicity and carcinogenicity of metronidazole. Mutat. Res. 317(3): 177-194.
14. Edwards DI. 1986. Reduction of nitroimidazoles and DNA damage. Biochemcal Pharmacology 35: 53-58.
15. Feng S, Kong Z, Wang X, Peng P, Zeng EY. 2005. Assessing the genotoxicity of imidacloprid and RH-5849 in human peripheral blood lymphocytes in vitro with comet assay and cytogenetic tests. Ecotox. Environ. Safety 61: 239-246.
16. Gaddini L, Pelliccia F, Limongi M, Rocchi A. 1995. Study of the relationships between common fragile sites, chromosome breakages and sister chromatid exchanges. Mutagenesis 10(3): 257-260.
17. Glover T, Stein C. 1987. Induction of sister chromatid exchanges at common fragile sites. Am. J. Hum. Genet. 41(5): 882-890.
18. Goldman P, Koch RL, Yeung TC, Chrystal EJ, Beaulieu BB Jr, McLafferty MA, Sudlow G, 1986. Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity. Biochem. Pharmacol. 35: 43-51.
19. Guglielmi GE, Vogt TF, Tice RR. 1982. Induction of sister chromatid exchanges and inhibition of cellular proliferation in vitro, I. Caffeine. Environm. Mutagen. 4: 191-200.
20. Hartley-Asp B. 1979. Metronidazole exhibits no cytogenetic effect in the MN test or in human lymphocytes in vitro. Mutat. Res. 67: 193-196.
21. Hirsch B. 1991. Sister chromatid exchanges are preferentially induced at expressed and nonexpressed common fragile sites. Hum. Genet. 87: 302-306.
22. Kiuru A, Lindholm C, Auvinen A, Saloma S. 2000. Localization of radiation- induced chromosomal breakpoints along human chromosome 1 using a combination of G-banding and FISH. Int. J. Radiat. Biol. 76(5): 667-672.
23. Kolomietz E, Meyn M, Pandita A, Squire J. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35(2): 97-112.
24. LaRusso NF, Tomasz M, Müller M, Lipman R. 1997. Interaction of Metronidazole with nucleic acids in vitro.Mol.Pharmacol 13: 872-882.
25. Latt S, Allen J, Bloom S, Carrano A, Falke E, Kram D, Schneider E, Schreck R, Tice R, Whitfield B, Wolff S. 1981. Sister-chromatid exchanges: a report of the Gene-Tox Program. Mutat. Res. 87: 17-62.
26. Lerda D, Biaggi Bistoni M, Peralta N, Ychari S, Vazquez M, Bosio G. 2005. Fumonisins in foods from Cordoba (Argentina), presence and genotoxicity. Food Chem. Toxicol. 43: 690-698.
27. Loesche WJ, Schmidt E, Smith BA, Morrison EC, Caffesse R, Hujoel PP. 1991. Effects of Metronidazole on periodontal treatment needs. J. Periodontal 62(4): 247-257.
28. López-Nigro M, Palermo A, Mudry M, Carballo MA. 2003. Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol. in Vitro 17: 35-40.
29. Ludlum DB, Colinas RJ, Kirk MC, Mehta JR. 1988. Reaction of reduced metronidazole with guanosine to form an unstable adduct. Carcinogenesis 9: 593-596.
30. Madia F, Gattazzo C, Wei M, Fabrizio P, Burhans WC, Weinberger M, Galbani A, Smith RJ, Nguyen C, Huey S, Comai L, Longo VD. 2008. Longevity mutation in SCH9 prevents recombination errors and premature genomic instability in a Werner/Bloom model system. J. Cell Biol. 180(1): 67-81.
31. Martelli A, Allavena A, Robbiano L, Mattioli F, Brambilla G. 1990. Comparison of sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole. Pharmacol. Toxicol. 66: 329-334.
32. Martindale W. 1993. Plasmatic concentrations of antiparasitic drugs in man. In Extra Pharmacopoeia, Reynolds J (ed.) The Pharmaceutical Press: London; 516-523.
33. Matula T. 1990. Validity of in vitro testing. Drug Metab. Rev. 22: 777-787.
34. Miller BM, Adler ID. 1989. Suspect spindle poison: analysis of c-mitotic effect in mouse bone marrow cells. Mutagenesis. 4(3): 208-215.
35. Mudry M, Carballo MA, Labal de Vinuesa M, González Cid M, Larripa I. 1994. Mutagenic bioassay of certain pharmacological drugs. III. Metronidazole (MTZ). Mutat. Res. 305: 127-132.
36. Mudry M, Martinez-Flores I, Palermo A, Carballo MA, Egozcue J, García- Caldés M. 2001. Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus. Teratogenesis Carcinogen. Mutag. 21: 197-205.
37. Neal SB, Probst GS. 1983. Chemically-induced sister chromatid exchange in vivo in bone marrow of chinese hamster. An evaluation of 24 compounds. Mutat. Res. 113: 33-43.
38. Ochi H, Douglas H, Sandberg A. 1986. Cytogenetic studies in primary gastric cancer. Cancer Genet. Cytogenet. 22(4): 295-307.
39. On line Mendelian Inheritance in Man. 2003. On line sequenced database of the human genome. Johns Hopkins University, MA. Available at: http//www.nih.ncbi.gov
40. Palermo AM, Reynoso AS, López Nigro M, Mudry MD, Carballo MA. 2004. Teratogenic evaluation of metronidazole and ornidazole using Drosophila melanogaster. Birth Defects Res. (Part A): Clin. Mol. Teratol. 70(4): 157-162.
41. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce C. 2002. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol. 3(12): 748-754.
42. Perry P, Evans H. 1975. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature 258: 121-125.
43. Perry P, Wolf S. 1974. New Giemsa method for differential staining of sister chromatids. Nature 261: 156-158.
44. Raether W, Hanel H. 2003. Nitroheterocyclic drugs with broad spectrum activity. Parasitol. Res. 90: 19-39.
45. Re JL, De Méo MP, Laget M, Guiraud H, Castegnaro M, Vanelle, P, Duménil G. 1997. Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay. Mutat. Res. 375: 147-155.
46. Rodriguez Ferreiro G, Cancino Badías L, López Nigro M, Palermo A, Mudry M, Prieto Gonzalez E, Carballo MA. 2002. DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives. Toxicol. Lett. 171 : 215-222.
47. Rudd MK, Friedman C, Pargi SS, Linardopoulou EV, Hsu L, Trask BJ. 2007. Elevated rates of Sister Chromatid Exchange at chromosome ends. Plos Genet. 3(2): 319-323.
48. Rustia M, Shubik P. 1979. Experimental induction of hepatomas mammary tumors and others with metronidazole in non inbred Sas: MRC (W1)BR rats. J. Natl Cancer Inst. 63: 863-868.
49. Satanimirovic Z, Stevanovic J, Jovanovic S, Andjelkovic M. 2005. Evaluation of genotoxic effects of Apitol (cymiazole hydrochloride) in vitro by measurement of sister chromatid exchange. Mutat. Res. 588: 152-157.
50. Schinkel AH, Jonker JW. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55: 3-29.
51. Schmid O, Speit G. 2007. Genotoxic effects induced by formaldehyde in human blood and implications for the interpretation of biomonitoring studies. Mutagenesis 22(1): 69-74.
52. Schwartz S, Astermborski J, Budacz A, Boughman J, Wasserman S, Cohen M. 1990. Repeated measurement of spontaneous and clastogen induced sister chromatid exchange. Mutat. Res. 234: 51-59.
53. Sen SK, Kan H, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA. 2006. Human genomic deletions mediated by recombination between Alu elements. Am. J. Hum. Genet. 79: 41-53.
54. Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Takahashi M, Shimokata K. 2001. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene 20(31): 4249-4257.
55. Sutherland GR, Richard GI. 1999. Fragile sites-cytogenetic similarity with molecular diversity. Am. J. Hum. Genet 64(2): 354-359.
56. Tedeschi B, Vernole L, Sanna M, Nicoletti B. 1992. Population genetics of aphidicolin induced fragile sites. Hum. Genet. 89(5): 543-547.
57. Tossiti M, Arvelo F. 2001. Analysis of the distribution pattern of sister chromatid exchanges in mitotic chromosomes of human T-lymphocytes. Cytobios 105(410): 163-176.
58. Tucker, J, Preston, R. 1996. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment. Mutat. Res. 365: 147-159.
59. Tucker J, Auletta A, Cimino M, Dearfield L, Jacobson-Kram D, Tice R, Carrano A. 1993. Sister-chromatid exchange: second report of the Gene-Tox program. Mutat. Res. 297: 101-180.
60. Vercauteren P, Meulepas E, Vlietinck R, Cassiman J, Van den Berghe H. 1986. Non-uniform distribution of sister chromatid exchanges in human lymphocytes. Chromosoma 93(3): 197-202.
61. Walton MI, Workman P. 1987. Nitroimidazole bioreductive metabolism: quantitation and characterisation of mouse tissue benzimidazole nitro reductase in vivo and in vitro. Biochem. Pharmacol. 36: 883-896.
62. Wenger, S. 1995. Chemical induction of sister chromatid exchange at fragile sites. Cancer Genet. Cytogenet. 5(1): 72-74.